Hide Board Information

Show Board Information

Aventine Rnw Energy AVRW

Board Mod: trooperstocks

Asst Mods:

Last Post: 12/16/2024 9:35:11 AM

Board Marks: 1

Posts Today: 0

Board Views Today: 3

Aventine Rnw Energy (OTCMRKTS: AVRW) Stock Message Board

1. AVRW Company Profile

    

2. AVRW Time & Sales

    

3. AVRW Recent News

    

4. AVRW Filings

    

5. AVRW Financials

    

6. AVRW Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

6	$AVRW News: Avenir Wellness Solutions Announces	Lee Adams	12/16/2024 9:35:11 AM
5	Interview with Nancy Duitch, CEO Avenir Wellness	Lee Adams	07/02/2024 10:40:07 AM
4	$AVRW NEWS: Avenir Wellness Solutions Reports (1)	trooperstocks	05/17/2024 2:08:29 PM
3	AVRW Financials Tuesday, July 15, 2014 6:42:14 PM	Emylers	07/15/2014 6:42:14 PM
2	AVRW 20.00 Stock Charts $AVRW 1 Month Chart	chartguy89	03/06/2014 12:46:48 AM
1	AVRW Stock Charts Sunday, February 23, 2014 at	chartguy89	02/23/2014 3:29:50 AM

Recent Articles

• Ensurge Micropower ASA Partners with Corning to Enhance Microbattery Tech
• Collaborative Efforts to Revolutionize Solid-State Microbatteries
• Griffin Global Asset Management Closes Record $1.245 Billion Deal
• IONX and Virgin Media O2 Lead 5G Transformation in the UK
• Consumers Embrace GenAI for Year-End Sales Strategies
• The Secret Behind Millionaires Paying Off Mortgages Early
• HTX Celebrates Award Recognition in Web3 Industry
• Impacts and Insights from the Ongoing Government Shutdown
• Changpeng Zhao's Bold Move with Aster Token Ignites Market Buzz
• Akeso Achieves Milestone with New Cancer Treatment Designation
• Trump's Tariffs Controversy: Why He Stays Away from Court
• Savara Inc. Legal Update: What Investors Need to Know
• V.F. Corporation Investors Should Be Aware of Class Action
• Engwe Unveils Advanced E-Bikes at Major Milan Event
• Trump's Unique Views on Cryptocurrency and His Family's Role
• Concluding Highlights of the Financial Street Forum 2025 Events
• Stock Market Update: Nasdaq Climbs as Earnings Surprise Investors
• Stocks to Keep an Eye on This Monday: Key Updates & Insights
• Trump's Stance on Nvidia's Blackwell AI Chip and Its Future
• 2025 Gold Glove Award Winners Announced: Defensive Excellence
• Faraday Future Welcomes Chris Nixon Cox as Strategic Advisor
• Tronox Holdings Investors Urged to Take Action Before Deadline
• How the Surge in AI Usage is Impacting Our Energy Bills
• Cryptocurrency Market Update: Key Insights on BTC, ETH, and More
• Aquilius Achieves Record-Breaking Fundraising Success
• GFM Services Berhad Earns Leadership Recognition for Innovation
• AgiBot Pioneers Reinforcement Learning in Robotics Deployment
• Aquilius Secures $1.1 Billion for Asia Pacific Real Estate Fund
• AgiBot Unveils Milestone in Reinforcement Learning Robotics
• Aquilius Secures Unprecedented $1.1 Billion for Real Estate Growth
• Exploring the Renaissance of Baijiu: A Global Affair
• Nota AI's KOSDAQ Listing Marks a New Era for AI Innovations
• Faraday Future Expands Operations with Strategic Partnerships
• Bitget and Fasanara Capital Unite for Enhanced Digital Asset Liquidity
• WPP plc Investors Urged to Act Before Class Action Deadline
• HUTCHMED Showcases Innovative Cancer Treatments at Recent Event
• Benitec Biopharma's Latest Update: Advancing Gene Therapy Research
• Benitec Biopharma Updates Phase 1b/2a Study for OPMD
• HUTCHMED Advances Innovative Cancer Treatments and Pipeline
• Join the Movement: Stand Up Against Fraud with Rosen Law
• SAMURAI Paint Unveils Innovative Car Spray Paint Series
• FireFly Welcomes New Non-Executive Director with Vast Industry Expertise
• Dave Ramsey's Critique of Congressional Incompetence
• Critical Insights on Savara Inc. and the Upcoming Class Action
• FireFly Metals Welcomes Experienced Director to the Team
• Discovering Innovations in Vascular Treatments from The VEINS 2025
• Lantheus Holdings Class Action: What Investors Need to Know
• Unveiling America's Tech Revolution: Buck Sexton's Insights
• Alvotech Faces Challenges in Biologics License Approval Process
• Alvotech's Progress on FDA Review for AVT05 Biosimilar